News & Updates

Show Multimedia Only

One-time screening in never-smokers a game-changer in lung cancer

01 Apr 2026 by

Data from a large, prospective, non-randomized study in China show that one-time low-dose computed tomography (LDCT) screening is associated with a significant reduction in lung cancer mortality in a non–risk-based population, including those who have never smoked.

01 Apr 2026

Preworkout dietary supplement use in young people linked to shorter sleep

01 Apr 2026

Adolescents and young adults who use preworkout dietary supplements are sleeping an average of not more than 5 h every night, as shown in a study.

01 Apr 2026

GLP-1RAs may offer histologic benefits in adults with MASH

01 Apr 2026 by

Among adults with biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH), treatment with glucagon-like peptide 1 receptor agonists (GLP-1RAs), particularly semaglutide or liraglutide, is associated with higher rates of MASH resolution without worsening of fibrosis compared with placebo, according to a recent Singapore study.

01 Apr 2026

BP-lowering via RAAS inhibition delivers better outcomes in paediatric CKD

31 Mar 2026 by

In the management of hypertension in paediatric chronic kidney disease (CKD), renin-angiotensin-aldosterone system inhibition (RAASi) is associated with better kidney function preservation and blood pressure control compared with calcium channel blockade, according to a real-world comparative-effectiveness study.

31 Mar 2026

Overwork stirs depressive, anxiety symptoms in migrant workers

31 Mar 2026 by

High resilience appears protective against the development of depressive and anxiety symptoms among migrant workers (MWs) and migrant domestic workers (MDWs) in Singapore, suggests a study.

31 Mar 2026

Orforglipron: The new kid on the weight loss runway?

31 Mar 2026 by

The novel oral, non-peptide glucagon-like peptide-1 receptor agonist (GLP-1 RA) orforglipron gains the upper hand over the current leading oral GLP-1 RA, semaglutide, in individuals with type 2 diabetes (T2D) inadequately controlled on metformin in the phase III ACHIEVE-3 study.

31 Mar 2026

Metformin may protect against esophageal squamous cell carcinoma

31 Mar 2026

Metformin users appear to have a reduced risk of esophageal squamous cell carcinoma (ESCC) compared with nonusers, as shown in a population-based study.

31 Mar 2026

Migraine care in Southeast, East Asia remains suboptimal: study

30 Mar 2026 by

Physicians across Southeast and East Asia describe significant gaps and inequalities in migraine care in the region, driven by specialist shortage, diagnostic delay, reliance on nonspecific medications, and limited access to migraine-specific therapies, as reflected in survey data from the SEALANT study.

30 Mar 2026